James S. Miser's most recent trade in Lixte Biotechnology Holdings Inc was a trade of 200,000 Stock Options done . Disclosure was reported to the exchange on Nov. 6, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lixte Biotechnology Holdin... | James S. Miser | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2022 | 200,000 | 200,000 | - | - | Stock Options |